Coegin Pharma AB is a biopharmaceutical company focused on developing innovative therapies for a range of medical conditions, particularly in the field of oncology and inflammation. The company leverages proprietary technologies and a deep understanding of specific molecular pathways to design and develop small molecule therapeutics aimed at targeting chronic diseases. Notably, Coegin Pharma AB prioritizes the discovery and development of treatments for skin cancer and related dermatological disorders. With an emphasis on early-stage research and clinical development, Coegin Pharma AB seeks to collaborate with academic institutions and industry partners to advance its pipeline of candidate compounds. Through its initiatives, the company aims to address unmet medical needs and contribute significantly to the healthcare and life sciences sectors, presenting a key role in pioneering novel treatment options in its focus areas.